Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
0(0%)
Results Posted
25%(2 trials)
Terminated
1(9%)

Phase Distribution

Ph not_applicable
9
82%
Ph phase_4
2
18%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution11 total trials
Phase 4Post-market surveillance
2(18.2%)
N/ANon-phased studies
9(81.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(8)
Terminated(1)
Other(1)

Detailed Status

Completed8
Not yet recruiting1
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Phase 42 (18.2%)
N/A9 (81.8%)

Trials by Status

not_yet_recruiting19%
completed873%
unknown19%
terminated19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11